摘要
目的:探讨利伐沙班治疗急性门静脉血栓形成的疗效。方法:9例急性门静脉血栓形成病人(男性8例,女性1例)服用利伐沙班治疗,剂量10 mg,每日1次,观察门静脉复通时间、复通率及治疗期间的并发症。结果:门静脉复通平均时间36 d,其中8例完全复通,1例大部分复通。治疗期间未发现继发性出血等不良反应。结论:利伐沙班治疗急性门静脉血栓形成的疗效良好且使用方便。
Objective: To investigate the efficacy of Rivaroxaban in the treatment of acute portal vein thrombosis. Methods: 9 patients (8 men and 1 woman) with acute portal vein thrombosis were treated by Rivaroxaban with the dosage of 10 mg daily. The time and rate of recanalization and the complications during the anticoagulant therapy were observed. Results: The mean recanalization time of portal vein was 36 d. 8 cases had complete recanalization and the other one had partial recanalization. No sencondary bleeding happened during the anticoagulant therapy. Conclusion: The treatment with Rivaroxaban in the patients sufferring from acute portal vein thrombosis is safe and convenient.
出处
《岭南急诊医学杂志》
2013年第5期347-348,共2页
Lingnan Journal of Emergency Medicine